News  |
  •   IDP-410: First direct N-MYC protein inhibitor deli...
  •   Annual Meeting of the American Association for Can...
  • LEADERSHIP
  • PIPELINE
  • SAB
  • PARTNERSHIPS
  • IDP TARGETS
  • PUBLIC FUNDING
    • RETOS COLABORATIVO 2016-2019
    • Project Nuclis ACCIO
    • RETOS COLABORATIVO 2017
  • NEWS
  • CONTACT

IDP Pharma and BCN Peptides initiates a collaboration

news
03 April 2017

IDP Pharma and BCN Peptides engage in the development of a new chemical entity aimed to treat Multiple Myeloma. The collaborative project has been granted with funds from the European Union FEDER via ACCIO and its programme «Nuclis d’Innovació Tecnológica».

About the Author

Co-Founder.

Latest blog posts

Latest news

Archives

  • febrero 2022 (1)
  • octubre 2020 (1)
  • diciembre 2019 (1)
  • junio 2019 (1)
  • abril 2019 (1)
  • septiembre 2018 (1)
  • marzo 2018 (2)
  • febrero 2018 (1)
  • julio 2017 (1)
  • abril 2017 (2)
  • enero 2017 (1)
  • mayo 2016 (2)
  • junio 2015 (1)
  • marzo 2015 (1)

Blog

Latest news

Social Networks


Corporate Factsheet
Terms of Use
Privacy Policy
IDP Pharma © 2016 - Powered by AppexStudio
comprar cialis generico   .. cialis online
x
Login
Forgot password?
Click here »
x
Register